This Rekha Jhunjhunwala-backed biotech firm made market debut today. See how its value zoomed

Concord Biotech Ltd, supported by RaRe Enterprises, saw its shares surge by 33.3% in early trades, reaching a valuation of over ₹10,300 crore.